Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00177268 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    Site contact updated

    Study Status, Oversight, Contacts/Locationsv23

  2. Minor

    Site contact updated

    Study Status, Oversight, Contacts/Locationsv22

  3. Minor

    Site contact updated

    Study Status, Contacts/Locationsv21

  4. Minor

    Study Identification, Study Status

    Re-verified, no change to tracked fields

    v20

  5. Minor

    Site contact updated

    Study Status, Contacts/Locationsv19

Show 17 earlier versions

  1. Minor

    Study Status

    Re-verified, no change to tracked fields

    v18

  2. Notable

    Primary completion date: Jan 2027 to Jan 2030

    Completion date: Jan 2028 to Jan 2032; Site contact updated

    Study Status, Contacts/Locationsv17

  3. Minor

    Site contact updated

    Study Status, Contacts/Locationsv16

  4. Notable

    Primary completion date: Jan 2023 to Jan 2027

    Completion date: Jan 2024 to Jan 2028; Site contact updated

    Study Status, Contacts/Locationsv15

  5. Minor

    Interventions: Blood draw or skin biopsy (Other) to Blood draw, skin biopsy or urine collection (Other)

    Study Status, Arms and Interventionsv14

  6. Minor

    Study Status, Study Design

    Re-verified, no change to tracked fields

    v13

  7. Notable

    Primary completion date: Jan 2022 to Jan 2023

    Completion date: Jan 2023 to Jan 2024; Site contact updated

    Study Status, Sponsor/Collaborators, Conditions, Contacts/Locations, IPDSharingv12

  8. Minor

    Study Status

    Re-verified, no change to tracked fields

    v11

  9. Minor

    Eligibility criteria expanded, about 11 words

    Study description expanded, about 5 words; Site contact updated; Study title expanded, about 5 words

    Show what changed: Eligibility criteria
    Inclusion Criteria: 18 or older able and willing to provide informed consent diagnosed with CTCL diagnosed with either atopic dermatitis or eczema Exclusion Criteria: Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
    Show what changed: Study description
    The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: immunologic assays/flow cytometry tumo [...]
    Show what changed: Study title
    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

    Study Identification, Study Status, Study Description, Arms and Interventions, Eligibility, Contacts/Locationsv10

  10. Notable

    Primary endpoint revised

    Site contact updated

    Show what changed: Primary endpoints
    ProteonomicsProteomics of Cutaneous T-cell lymphoma

    Study Status, Outcome Measures, Contacts/Locationsv9

  11. Minor

    Primary completion date: Jan 2022

    Completion date: Jan 2012 to Jan 2023; Site contact updated

    Study Status, Sponsor/Collaborators, Conditions, Outcome Measures, Contacts/Locationsv8

  12. Minor

    Site contact updated

    Study Status, Contacts/Locationsv7

  13. Minor

    Completion date: Jan 2010 to Jan 2012

    Site contact updated

    Study Status, Contacts/Locationsv6

  14. Minor

    Study Status

    Re-verified, no change to tracked fields

    v5

  15. Minor

    Study Status, Sponsor/Collaborators, Oversight, Study Design, Arms and Interventions, Eligibility

    v4

  16. Minor

    Site contact updated

    Study Status, Contacts/Locationsv3

  17. Minor

    Site contact updated

    Study Status, Contacts/Locationsv2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Trial Details
NCT Number NCT00177268
Lead Sponsor University of Pittsburgh
Conditions Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides, Eczema, Atopic Dermatitis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov